Endovascular interventions in iliac and infrainguinal occlusive artery disease

Journal of Interventional Cardiology

Volumn 17, Issue 6, 2004, Pages 427-435

  Ruef, Johannes ^a,b   Hofmann, Manfred ^a   Haase, Jürgen ^a  

^a Red Cross Hospital Cardiology Center   (Germany)

^b Kardiologisches Centrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL; POLITEF; RAPAMYCIN;

ARTERY INTIMA; ARTERY RECONSTRUCTION; ATHERECTOMY; BALLOON; BIODEGRADABLE IMPLANT; BIODEGRADABLE STENT; BRACHYTHERAPY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CRYOPLASTY; CRYOTHERAPY; CUTTING BALLOON; DRUG EFFICACY; DRUG ELUTING STENT; ENDOVASCULAR INTERVENTION; FEMORAL ARTERY; FEMOROPOPLITEAL ARTERY; HUMAN; ILIAC ARTERY OBSTRUCTION; INFRAINGUINAL OCCLUSIVE ARTERY DISEASE; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LASER ANGIOPLASTY; PERCUTANEOUS ENDOVASCULAR INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLITEF IMPLANT; POLITEF STENT GRAFT; POPLITEAL ARTERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SELF EXPANDING NITINOL STENT; STENT; SUBINTIMAL ANGIOPLASTY; THROMBECTOMY; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, BALLOON, LASER-ASSISTED; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; BRACHYTHERAPY; FEMORAL ARTERY; HUMANS; ILIAC ARTERY; LEG; POPLITEAL ARTERY; STENTS; VASCULAR PATENCY;

EID: 9244246806     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2004.04086.x     Document Type: Review

References (72)

1. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:538-545.
2. Diehm C, Schuster A, Allenberg JA, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: A cross-sectional study. Atherosclerosis 2004;172:195-205.
3. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: Description of a new technique and a preliminary report of its application. Circulation 1964;30:654-670.
4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Trans-Atlantic Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
5. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170:921-940.
6. Palmaz JC, Garcia OJ, Schatz RA, et al. Placement of balloon-expandable intraluminal stents in iliac arteries: First 171 procedures. Radiology 1990;174:969-975.
7. Vorwerk D, Günter RW, Schürmann K, et al. Aortic and iliac stenoses: Follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology 1996;198:45-48.
8. Vorwerk D, Günter RW, Schürmann K, et al. Primary stent placement for chronic iliac occlusions: Follow-up results in 103 patients. Radiology 1995;194:745-749.
9. Schürmann K, Mahnken A, Meyer J, et al. Long-term results 10 years after iliac arterial stent placement. Radiology 2002;224:731-738.
10. Bosch JL, Hunink MGM. Metaanalysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997;204:87-96.
11. Richter GM, Roeren T, Brado M, et al. Arterial stenting: Randomized trial between primary iliac stenting vs PTA in iliac artery stenosis and obstruction. Eur J Radiol 1995;5:103.
12. Tetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Lancet 1998;351:1153-1159.
13. Thalhammer A, Balzer J, Jacobi V, et al. Stents in the iliac arteries: A minimally invasive method. Hämostaseologie 2003;23:67-70.
14. Scheinert D, Schröder M, Ludwig J, et al. Stent-supported recanalization of chronic iliac artery occlusions. Am J Med 2001;110:708-715.
15. Henry M, Henry I, Klonaris C, et al. Clinical experience with the OptiMed sinus stent in the peripheral arteries. J Endovasc Ther 2003;10:772-779.
16. Comerota AJ. Endovascular and surgical revascularization for patients with intermittent claudication. Am J Cardiol 2001;87:34D-43D.
17. Wolf GL, Wilson SE, Cross AP, et al. Surgery or balloon angioplasty for peripheral vascular disease: A randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol 1993;4:639-648.
18. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. J Vasc Surg 1989;9:1-9.
19. Spies JB, Bakal CW, Burke DR, et al. Guidelines for percutaneous transluminal angioplasty. J Vasc Interv Radiol 2003;14:5209-5217.
20. Isner JM, Rosenfeld K. Redefining the treatment of peripheral arterial disease: Role of percutaneous revascularization. Circulation 1993;88:1534-1537.
21. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> 10 cm) femoropopliteal angioplasty: Improved technical success and long term patency. Radiology 1995;195:158-162.
22. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long segment superficial artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
23. Johnston KW. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771.
24. Gallino A, Mahler F, Probst P, et al. Percutaneous transluminal angioplasty of the arteries of the lower limbs: A 5 year follow-up. Circulation 1984;70:619-623.
25. Lammer J. Femoropopliteal artery obstructions: From the balloon to the stem-graft. Cardiovasc Intervent Radiol 2001;24:73-83.
26. Bergeron P, Pinot JJ, Poyen V, et al. Long-term results with the Palmaz-stent in the superficial femoral artery. J Endovasc Surg 1995;2:161-167.
27. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoro-popliteal artery obstructions: A multicenter prospective randomized study. J Vasc Intervent Radiol 2001;12:23-31.
28. Lampmann LE. Stenting in the superficial femoral artery: An overview. Eur J Radiol 1999;29:276-279.
29. Grimm J, Müller-Hülsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Intervent Radiol 2001;12:935-941.
30. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg 2004;45:193-201.
31. Muradin GS, Bosch JL, Stijnen T, et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: Meta-analysis. Radiology 2001;221:137-145.
32. Vogel TR, Shindelman LE, Nackman GB, et al. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg 2003;38:1178-1184.
33. Jahnke T, Voshage G, Müller-Hülsbeck S, et al. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoro-popliteal obstructive disease. J Vasc Intervent Radiol 2002;13:257-266.
34. Fontaine AB, Spigos DG, Eaton G, et al. Stent-induced intimal hyperplasia: Are there fundamental differences between flexible and rigid stent designs? J Vasc Interv Radiol 1994;5:739-744.
35. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: Technique and mid-term results. Tech Vasc Interv Radiol 2004;7:2-5.
36. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: A midterm follow-up. Radiology 2002;222:37-43.
37. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: Factors influencing long-term success. Circulation 1991;83:170-180.
38. Hunink MGM, Wong JB, Donaldson MC, et al. Revascularization of femoropopliteal disease: A decision and cost-effectiveness analysis. JAMA 1995;274:165-171.
39. Schillinger M, Exner M, Mlekusch W, et al. Endovascular revascularization below the knee: 6 month-results and predictive value of C-reactive protein level. Radiology 2003;227:419-425.
40. Söder H, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: Angiographic and clinical results. J Vasc Intervent Radiol 2000;11:1021-1031.
41. Lofberg AM, Lorelius LE, Karacagil S, et al. The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol 1996;19:317-322.
42. Schwarten DE, Cutcliff WB. Arterial occlusive disease below the knee: Treatment with percutaneous transluminal angioplasty performed with low-profile catheters and steerable guide wires. Radiology 1988;169:71-74.
43. Dorros G, Jaff MR, Dorros AM, et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: Five-year follow-up. Circulation 2001;104(17):2057-2062.
44. Nasr MK, McCarthy RJ, Hardman J, et al. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischemia. Eur J Endovasc Surg 2002;23:398-403.
45. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation 2002;106:1505-1509.
46. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: Results of a prospective randomized study. Circulation 2000;102:2694-2699.
47. Pokrajac B, Schmid R, Poetter R, et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: Results of the Vienna-3 multicenter study. Int J Radiat Oncol Biol Phys 2003;57(2 Suppl. 1):250 (Abstract).
48. Wolfram RM, Pokrajac B, Ahmadi R, et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoro-popliteal placement of stents: Initial results. Radiology 2001;220:724-729.
49. Bonvini R, Baumgartner I, Do DD, et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 2003;41:409-412.
50. Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the SFA by subintimal dissection. Cardiovasc Interven Radiol 1990;13:357-363.
51. Reekers JA, Bolia A. Percutaneous intentional extraluminal recanalisation: How to do it yourself. Eur J Radiol 1998;28:192-198.
52. London NJM, Srinivasan R, Naylor AL, et al. Subintimal angioplasty of femoropopliteal angioplasty occlusions: The long term results. Eur J Vasc Surg 1994;8:148-155.
53. Loftus IM, Hayes PD, Bell PRF. Subintimal angioplasty in lower limb ischemia. J Cardiovasc Surg 2004;45:217-229.
54. Laxdal E, Jenssen GL, Pedersen G, et al. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Endovasc Surg 2003;25:578-582.
55. Lipsitz EC, Veith FJ, Ohki T. The value of subintimal angioplasty in the management of critical lower extremity ischemia: Failure is not always associated with a rethreatened limb. J Cardiovasc Surg 2004;45:231-237.
56. Scheinert D, Laird JR, Schroder M, et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther 2001;8:156-166.
57. Laird JR. Peripheral Excimer Laser Angioplasty (PELA) Trial results. 2002 (Abstract).
58. Laird JR, Reiser C, Biamino G, et al. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. J Cardiovasc Surg 2004;45:239-248.
59. Steinkamp HJ, Rademaker J, Wissgott C, et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther 2002;9:882-888.
60. Zeller T, Frank U, Burgulin K, et al. Initial clinical experience with percutaneous atherectomy in the infragenicular arteries. J Endovasc Ther 2003;10:987-993.
61. Zeller T, Frank U, Bürgelin K, et al. Early experience with a rotational thrombectomy device for treatment of acute and subacute infra-aortic arterial occlusions. J Endovasc Ther 2003;10:322-331.
62. Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 2004;61:1-4.
63. Dhar, A. Cutting balloon angioplasty in infrapopliteal arteries for better immediate and long term patency. J Cardiovasc Surg 2004;45(Suppl. 1-3):12 (Abstract).
64. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent graft versus angioplasty in the femoro-popliteal artery: Single center experience from a prospective, randomized trial. Vasc Interv Radiol 2003;14:303-311.
65. Jahnke T, Andresen R, Müller-Hülsbeck S, et al. Hemobahn stent grafts for the treatment of femoropopliteal arterial obstructions: Midterm results of a prospective trial. J Vasc Interv Radiol 2003;14:41-51.
66. Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003;89:651-656.
67. Brambillal N, Laudisa ML, Llambro M, et al. Cryoplasty in the treatment of iliac and superficial femoral disease. J Cardiovasc Surg 2004;45(Suppl. 1-3): 12 (Abstract).
68. Council on Scientific Affairs, American Medical Association. Percutaneous transluminal angioplasty. JAMA 1984;251:764-768.
69. Jamsen TS, Manninen HI, Jaakkola PA, et al. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 2002;225:345-352.
70. Schainfeld RM. Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature. Catheter Cardiovasc Interv 2002;56:421-431.
71. Perkins JM, Collin J, Creasy TS, et al. Exercise training versus angioplasty for stable claudication: Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996;11:409-413.
72. Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 1997;26:551-557.